HR 2223
110th Congress
House
Health
Congressional reporting requirements
Drugs
Environmental Protection
Environmental assessment
Governmental investigations
Pharmacies
Refuse and refuse disposal
To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.
Introduced: May 8, 2007
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 8, 2007
Referred to the Subcommittee on Health.
May 8, 2007
Referred to the House Committee on Energy and Commerce.
May 8, 2007
Introduced in House
Plain-English summary
Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs.
Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1